15
Livzon Pharma
1513.HK·HKEXZhuhai CNFounded 198515,000 employees
Mid CappharmaPublicGIOncology
Platform: Diversified
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (1513.HK)
Loading 1513.HK stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 151-9555 | 151-9555 | Phase 2/3 | 1 | B7-H3 | MCLOCD | ||
| Kemarelsin | 151-7518 | Phase 1/2 | 2 | WRN | Huntington's | ||
| Mirirasimod | 151-2613 | Approved | 3 | FLT3 | CMLAML |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Livzon Pharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)